The Senior Director, Clinical Science, Oncology Early Development provides strategic Clinical Science leadership for novel oncology assets from candidate transition through first-in-human development and clinical proof-of-concept. Reporting to the Executive Director, the role applies expertise in early-phase oncology, translational medicine, biomarker strategy, and first-in-human trial design to shape development plans, strengthen scientific rigor, and enable objective, data-driven decisions across the early oncology portfolio. The Senior Director integrates clinical, pharmacokinetic, pharmacodynamic, biomarker, safety, and external scientific evidence to inform indication strategy, dose escalation and optimization, cohort expansion, and proof-of-concept assessments. The role partners with Section Heads, Asset Leads, Early Program Development Team Leads, study teams, and cross-functional leaders on study design, data interpretation, issue resolution, and program decisions. It also advances consistent Clinical Science practices across the portfolio and may directly manage and develop multiple Clinical Scientists. The position collaborates with Clinical Operations, Regulatory Affairs, Biostatistics and Data Management, Drug Safety and Pharmacovigilance, Translational Medicine, Medical Affairs, and other functions. It contributes to governance discussions and senior leadership reviews. The role is based in Rahway, New Jersey, with a hybrid work arrangement and 10% travel.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior